Bicara Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bicara Therapeutics Inc
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
/ 
Frequently asked questions
To buy Bicara Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bicara Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bicara Therapeutics Inc is BCAX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bicara Therapeutics Inc has its primary listing on NASDAQ. You can trade Bicara Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bicara Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bicara Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bicara Therapeutics Inc.